Clinical Trial Update: Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial assessing micropulse trans-scleral cyclophotocoagulation laser (MP-TSCPC) for glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC)

Snippet

Sponsor: Mayo Clinic | Conditions: Glaucoma | Status: COMPLETED